OTTAWA, ON, Feb. 21, 2025 /PRNewswire/ - Esphera SynBio Inc. will be featured in an upcoming episode of Advancements, a television program hosted by Ted Danson and broadcast on the Bloomberg cable and ...

Earnings Call Insights: Twist Bioscience Corporation (NASDAQ:TWST) Q1 2025 CEO Emily Leproust highlighted record revenue of ...

The fourth SynBio Challenges (SC) taking place in Shenzhen, China, from August 6-9, drew over 265 university teams and nearly 1,900 young talents from across Asia. The competition featured seven major ...

Sign up for The Media Today, CJR’s daily newsletter. You know an urban neighborhood is up and coming when it gets an abbreviation like “SoMa,” for the district ...

The Share Purchase Agreement (SPA) secures an equity stake in FacialDx and secures ownership in its intellectual property by way of the shareholding. The SPA also enables Synbio to convert future ...

In today’s rapidly evolving scientific landscape, eliminating barriers to progress is more critical than ever. Precision medicine and targeted therapies hold great promise but are dependent on the ...

In Washington, DC, Xian-en Zhang, Director General, Basic Research Department, China Ministry of Science and Technology, stated that the People’s Republic of China is seeking to position itself as a ...

The combination of AI and synthetic biology could lead to the creation of novel organisms with unintended and potentially harmful consequences. The democratization of genetic engineering through ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

How synthetic biology is enabling bio-based alternatives for industrial processes, sustainable food systems, and breakthroughs in healthcare. The role of advanced gene-editing tools like CRISPR-Cas9 ...